DHODH-IN-31 is a human dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 0.59 µM. DHODH-IN-31 exhibits antiviral activity, enabling research into infectious diseases such as SARS-CoV-2 and facilitating the development of antiviral therapeutics and mechanistic studies of nucleotide biosynthesis pathways in human cells.
Molecular Weight:
313.35
Purity:
99.90%
Formula:
C20H15N3O
Target:
Dehydrogenase
T210457
* VAT and and shipping costs not included. Errors and price changes excepted
